Bandingkan Harga & Kinerja Lenox Pasifik Investama Tbk. (LPPS) vs Millennium Pharmacon International Tbk. (SDPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Lenox Pasifik Investama Tbk. dan Millennium Pharmacon International Tbk.: Lenox Pasifik Investama Tbk. diperdagangkan di Rp79 (kapitalisasi pasar 181,18 M, volume 24 jam 76,86 jt), sedangkan Millennium Pharmacon International Tbk. diperdagangkan di Rp182 (kapitalisasi pasar 230,59 M, volume 24 jam 66,7 rb). Perbedaan utamanya: Millennium Pharmacon International Tbk. lebih besar dari sisi kapitalisasi pasar, dan Lenox Pasifik Investama Tbk. lebih aktif diperdagangkan (76,86 jt vs 66,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LPPS | SDPC | |
|---|---|---|
Kapitalisasi Pasar | 181,18 M | 230,59 M |
Volume | 76,86 jt | 66,7 rb |
Lot | 768,6 rb | 667 |
Perputaran | 6,58 M | 12,15 jt |
Harga Rata-rata | 85,59 | 182,09 |
Nilai Transaksi | 6,58 M | 12,15 jt |
Harga Ekuilibrium Indikatif | 79 | 182 |
Volume Ekuilibrium Indikatif | 9,22 rb | 10 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Lenox Pasifik Investama Tbk.
PT Lippo Securities Tbk (the Parent Company) was established on June 20, 1989 based on notarial deed No.514 of Misahardi Wilamarta, S.H. The deed of establishment was approved by the Ministry of Justice of the Republic of Indonesia (MOJ) in its decision letter No.C2-6029.HT.01.01TH.89 dated July 6, 1989, and was published in the State of Gazette No.80 Supplement No. 3904 dated October 5, 1990. Its articles of association has been amended several times, most recently by notarial deed No.113 of Ny. Poerbaningsih Asi Warsito, S.H., dated July 30,1999, concerning among others, the adjustments to effect the Regulation No.IX.D.I. On December 20, 1999, the Parent Company submitted a letter to the Chief of the Capital Market Supervisory Board requesting for the revocation of its business license as broker, in connection with the merger of its brokering activities with PT Ciptadana Sekuritas, a subsidiary. This request was approved by the Chief of the Capital Market Supervisory Board based on its decision letter No. 01/PM/2000 dated January 5, 2000.In view of the foregoing, PT Bursa Efek Jakarta in its letter No.S.024/BEJ.ANG/01-2000 dated January 12, 2000 and PT Bursa Efek Surabaya in its letter No. T1-003/AGT/BES/I/2000 dated January 1, 2000, cancelled their Approval Letter on Stock Exchange Membership (Surat Persetujuan Anggota Bursa) issued to the Parent Company effective January 13, 2000 and January 4, 2000, respectively. Accordingly, the Parent Company is required to sell its investments in shares of stock of PT Bursa Efek Jakarta and PT Bursa Efek Surabaya.
Selengkapnya di halaman LPPS →Tentang Millennium Pharmacon International Tbk.
PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.
Selengkapnya di halaman SDPC →
